Diabetes Significantly Raises Risk of Complications Following Stent Implantation
Table of Contents
A new study reveals that patients with diabetes, particularly type 1 diabetes, face a substantially increased risk of complications after receiving coronary stents, highlighting the need for tailored treatment approaches.
A comprehensive analysis of data from over 160,000 patients, conducted by researchers at Karolinska Institutet in Sweden and published in Diabetes Care, underscores the critical importance of individualized care for individuals with diabetes undergoing stent implantation. The research, spanning the years 2010 to 2020, provides compelling evidence for a heightened risk of adverse events in this vulnerable patient population.
Increased Risk Across Diabetes Types
The study categorized patients into three groups – those with type 1 diabetes, those with type 2 diabetes, and those without diabetes – to assess the varying levels of risk. Researchers found that individuals with type 1 diabetes experienced more than double the risk of stent complications compared to those without the condition. While the risk was also elevated for patients with type 2 diabetes, it was not as pronounced. These complications encompass both the narrowing of the artery within the stent and the formation of blood clots.
“Our results show that people with diabetes, especially type 1 diabetes, have a much higher risk of stent complications,” explained a lead researcher from the Department of Clinical Science and Education at Karolinska Institutet. “Therefore, it is important to carefully consider how we treat these patients.”
Timing of Risk and Long-Term Implications
The research pinpointed the initial months following stent implantation as the period of highest risk. Specifically, during the first month, the incidence of stent complications reached 9.27 per 100 person-years for patients with type 1 diabetes, a significant increase compared to the 4.34 observed in patients without diabetes. Although the risk diminished after six months, it remained consistently higher for individuals with diabetes throughout the observation period.
This finding suggests a critical window for intensive monitoring and potential intervention following stent placement in diabetic patients. .
Call for Adaptive Treatment Strategies
The study’s findings emphasize the urgent need for further investigation into optimizing treatment protocols for diabetic patients undergoing stent implantation. According to a senior researcher involved in the study, “We need to continue to investigate how we can improve treatment for patients with diabetes who undergo stent implantation. Our results indicate that there is a need to adapt treatment and follow-up for them.”
This collaborative research effort, involving Karolinska Institutet and the Germans Trias i Pujol Institute in Barcelona, provides a crucial step toward improving outcomes for a growing population of patients with diabetes requiring coronary intervention.
More information: Coronary stent failure in patients with diabetes: A nationwide observational study from SWEDEHEART, Diabetes Care (2025). DOI: 10.2337/dc25-1624
